Robert M. Elashoff

Active 1966–2020

Also published as
ROBERT M. ELASHOFF
111
Papers
29,970
Citations
89
h-index
111
i10-index

Citations

Citations per year for Robert M. Elashoff1936: 1 citations1968: 2 citations1970: 1 citations1971: 1 citations1973: 2 citations1974: 2 citations1975: 8 citations1976: 3 citations1977: 7 citations1978: 4 citations1979: 13 citations1980: 3 citations1981: 14 citations1982: 8 citations1983: 11 citations1984: 9 citations1985: 7 citations1986: 9 citations1987: 6 citations1988: 5 citations1989: 12 citations1990: 11 citations1991: 14 citations1992: 23 citations1993: 23 citations1994: 21 citations1995: 29 citations1996: 31 citations1997: 37 citations1998: 37 citations1999: 56 citations2000: 58 citations2001: 88 citations2002: 107 citations2003: 167 citations2004: 155 citations2005: 179 citations2006: 183 citations2007: 181 citations2008: 214 citations2009: 238 citations2010: 193 citations2011: 227 citations2012: 219 citations2013: 267 citations2014: 206 citations2015: 232 citations2016: 198 citations2017: 164 citations2018: 202 citations2019: 788 citations2020: 736 citations2021: 631 citations2022: 454 citations2023: 313 citations2024: 513 citations2025: 222 citations2026: 10 citations1937–1967: no citations, so these years are not shown1969: no citations, so this year is not shown1972: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,173 citing papers, 32.7% of this breakdownUnited Kingdom: 711 citing papers, 7.3% of this breakdownGermany: 544 citing papers, 5.6% of this breakdownItaly: 534 citing papers, 5.5% of this breakdownCanada: 414 citing papers, 4.3% of this breakdownAustralia: 393 citing papers, 4% of this breakdownFrance: 378 citing papers, 3.9% of this breakdownChina: 374 citing papers, 3.9% of this breakdownNetherlands: 344 citing papers, 3.5% of this breakdownSwitzerland: 231 citing papers, 2.4% of this breakdownJapan: 231 citing papers, 2.4% of this breakdownSpain: 208 citing papers, 2.1% of this breakdown
0%32.7%Other 22.4%

Fields

  • Medicine75.4%
  • Biochemistry, Genetics and Molecular Biology10.6%
  • Immunology and Microbiology3.9%
  • Nursing2.3%
  • Neuroscience1.5%
  • Mathematics1.1%
  • Other5.2%

Topics

  • Cutaneous Melanoma Detection and Management4.2%
  • Systemic Sclerosis and Related Diseases3.9%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis3.7%
  • Parathyroid Disorders and Treatments3%
  • Immunotherapy and Immune Responses2.1%
  • Melanoma and MAPK Pathways2%
  • Other81.1%

Coauthors

All papers

Open in search
  1. Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

    Authors: , , , , - Gastroenterology 2011 cited by 931

  2. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard T. Meehan, Arthur C. Theodore, Robert W. Simms, Suncica Volkov, Dean E. Schraufnagel, Mary Beth Scholand, Tracy Frech, Jerry A. Molitor, Kristin B. Highland, Charles A. Read, Marvin J. Fritzler, Grace Hyun J. Kim, Chi‐Hong Tseng, Robert M. Elashoff - The Lancet Respiratory Medicine 2016 cited by 1,062

  3. Cyclophosphamide versus Placebo in Scleroderma Lung Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark L. Metersky - New England Journal of Medicine 2006 cited by 1,667

  4. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 556

  5. Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 1,462

  6. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tara L. Huston, Jeffrey D. Wayne, B. Mark Smithers, Heather B. Neuman, Schlomo Schneebaum, Jeffrey E. Gershenwald, Charlotte E. Ariyan, Darius C. Desai, Lisa K. Jacobs, Kelly M. McMasters, Anja Gesierich, Peter Hersey, Steven D. Bines, John M. Kane, Richard J. Barth, Gregory McKinnon, Jeffrey M. Farma, Erwin Schultz, Sergi Vidal‐Sicart, Richard Hoefer, James M. Lewis, Randall P. Scheri, Mark C. Kelley, Omgo E. Nieweg, R. Dirk Noyes, Dave S.�B. Hoon, He-Jing Wang, David Elashoff, Robert M. Elashoff - New England Journal of Medicine 2017 cited by 1,385

  7. CENSORING ISSUES IN SURVIVAL ANALYSIS

    Authors: , , - Annual Review of Public Health 1997 cited by 366

  8. Sentinel-Node Biopsy or Nodal Observation in Melanoma

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 1,826

  9. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts

    Authors: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 cited by 198

  10. Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2000 cited by 2,504

  11. Dietary Fat Reduction and Breast Cancer Outcome: Interim Efficacy Results From the Women's Intervention Nutrition Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2006 cited by 823

  12. Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

    Authors: , , , , , , , , , , , , , , , - Annals of Surgical Oncology 2017 cited by 140

  13. A Critical Analysis of the Clinical Use of Incretin-Based Therapies

    Authors: , , , - Diabetes Care 2013 cited by 296

  14. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

    Authors: , , , , , , , , , , - Arthritis & Rheumatology 2017 cited by 159

  15. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2015 cited by 201

  16. Testosterone Treatment in Multiple Sclerosis

    Authors: , , , , , , , , , , , - Archives of Neurology 2007 cited by 210

  17. Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide

    Authors: , , , , , , , , , , , , , - European Radiology 2011 cited by 123

  18. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease

    Authors: , , , , , , , , , , - Arthritis Research & Therapy 2016 cited by 86

  19. Sentinel Node Biopsy for Early-Stage Melanoma

    Authors: , , , , , , , , , , , , , - Annals of Surgery 2005 cited by 718

  20. Sustainability of Blood Pressure Reduction in Black Barbershops

    Authors: , , , , , , , , , , - Circulation 2018 cited by 124

  21. Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark L. Metersky, Dinesh Khanna, Ning Li, Gang Li - American Journal of Respiratory and Critical Care Medicine 2007 cited by 464

  22. High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

    Authors: , , , , , , , , , , , , - CHEST Journal 2008 cited by 244

  23. Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 452

  24. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients.

    Authors: , , , , , , , , , , - 2010 cited by 132